Corporate Profile
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients. We are more than 250 people working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, Cambridge, and South San Francisco.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
News Releases
Jun 14, 2021
Jun 02, 2021
May 05, 2021
Events
Jun 9, 2021 at 12:00 PM PDT
May 12, 2021 at 8:00 AM PDT
SEC Filings
| Filing date | Description | Form |
|---|---|---|
Report of unscheduled material events or corporate event |
8-K | |
Quarterly report which provides a continuing view of a company's financial position |
10-Q | |
Statement of changes in beneficial ownership of securities |
4 |